Detalles de la búsqueda
1.
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models.
Int J Clin Oncol
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38767719
2.
Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.
Cancer Sci
; 113(1): 240-250, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716979
3.
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.
Cancer Sci
; 113(5): 1693-1701, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218673
4.
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Gynecol Oncol
; 165(3): 413-419, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35487773
5.
A simplified procedure of nerve-sparing radical hysterectomy.
J Obstet Gynaecol Res
; 48(3): 766-773, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35052017
6.
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Int J Clin Oncol
; 26(1): 207-215, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960420
7.
Effects of pretreatment radiological and pathological lymph node statuses on prognosis in patients with ovarian cancer who underwent interval debulking surgery with lymphadenectomy following neoadjuvant chemotherapy.
J Obstet Gynaecol Res
; 47(1): 152-158, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32830400
8.
Evaluating the efficacy and safety of ureteral stent placement as a preoperative procedure for gynecological cancer surgeries: A retrospective cohort study.
J Obstet Gynaecol Res
; 47(8): 2752-2757, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975384
9.
Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma.
Reprod Med Biol
; 20(4): 467-476, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34646075
10.
A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer.
Br J Cancer
; 122(6): 766-770, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001833
11.
Deep vein thrombosis and serum D-dimer after pelvic lymphadenectomy in gynecological cancer.
Int J Gynecol Cancer
; 30(6): 860-864, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32276932
12.
Long-term evaluation of renal function and neurogenic bladder following radical hysterectomy in patients with uterine cervical cancer.
J Obstet Gynaecol Res
; 46(10): 2108-2114, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32686280
13.
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
Gynecol Oncol
; 155(1): 39-50, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427143
14.
Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
Int J Clin Oncol
; 24(12): 1612-1619, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31236742
15.
Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.
Br J Cancer
; 117(5): 717-724, 2017 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728166
16.
Serum Vascular Endothelial Growth Factor-A as a Prognostic Biomarker for Epithelial Ovarian Cancer.
Int J Gynecol Cancer
; 27(7): 1325-1332, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28557832
17.
Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.
Int J Clin Oncol
; 21(3): 580-7, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26614089
18.
Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Int J Clin Oncol
; 21(5): 969-974, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27142771
19.
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.
Int J Gynecol Cancer
; 25(4): 570-6, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25756405
20.
Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.
Int J Clin Oncol
; 20(5): 967-73, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25744580